Purpose and scope
The biosensor is intended to determine the microcourses of cytotoxic factors in human serum. The development can be applied in the institutions of the Ministry of Health of Ukraine.
The essence of the development
A highly sensitive cellular biosensor has been developed to detect cytotoxic compounds in patients with low concentrations (which are difficult to detect by analytical methods).
The emergencee of these cytotoxic compounds in the body triggers a cascade of immunological reactions that lead to the formation of pathologies, in particular myasthenia. The principle of the diagnostic method is based on the fact that cytotoxic compounds , interact with the cellular biosensor and lead to changes in its characteristics. The results are processed according to the developed program, and on the basis of this conclusion is made about the presence of autoimmune pathology and the stage of its development. Testing time is from 30 to 60 minutes. For analysis, 50 micro liters of patient blood serum is required.
Intellectual Property Protection Status
Patent of Ukraine is received.
Development is in demand in the Ukrainian market.
The state of readiness of development
A sample was created.